New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2025, WHO updated recommendations on HIV clinical management: recommendations for a public health approach
View latest version (2025)Bibliographic information
GuidelineConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year of Publication2016
Issuing InstitutionWHO
Recommendation
Retired
Originally developed
tenofovir disoproxil fumarate (TDF) + lamivudine (3TC ) or emtricitabine (FTC) + dolutegravir (DTG) or TDF + 3TC (or FTC) + efavirenz (EFV) 400 mg/day may be used as alternative options to initiate ART
Recommended in favor
Conditional
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO